MOHAMMED A. AL-BAYATI
Ph.D., D.A.B.T., D.A.B.V.T.
TOXICOLOGIST AND PATHOLOGIST
150 Bloom Dr.
Dixon, CA 95620
Phone: (707) 678-4484
FAX: (707) 678-8505
Email:maalbayati@toxi-health.com
EDUCATION AND BOARD CERTIFICATIONS
Ph.D. 1989 Comparative Pathology. University of California Davis, Davis, California.
Subject of studies: Human pathology, toxicology, pharmacology, medical immunology, medical biochemistry, analytical toxicology, environmental toxicology, and experimental toxicology.
Dissertation: Toxicokinetics and Toxicity of Vanadate
DABT 1994 Diplomate, American Board of Toxicology
II. Veterinary Pathology, Toxicology, Immunology, and Endocrinology
DABVT 1996 Diplomate, American Board of Veterinary Toxicology
M.V.Sc. 1978 Veterinary sciences. University of Cairo, College of
Veterinary Medicine, Cairo, Egypt
Subject of studies: Veterinary pathology and physiology.
Dissertation: Histopathological and histochemical changes in the adrenal glands of the Egyptian Buffalo with follicular cysts and inactive ovaries.
BVMS 1975 University of Baghdad, College of Veterinary Medicine,
Baghdad, Iraq.
Personal Information
United States Citizen
Languages: English and Arabic: speak, read, and write fluently
Qualifications in toxicology and biomedical sciences
TEACHING EXPERIENCE
WRITING RESEARCH GRANTS AND CONTRACTS AND SUPERVISING EXPERIENCE
Agency: AMGEN Pharmaceutical Inc. Thousand Oaks, CA 91320
Duration: 30 months (1993-1995)
Amount: $254,778, Position: PI
Agency: United States Environmental Protection Agency
Duration:48 months (1990-1995)
Amount: $980,000
Project Role: Co-PI
Agency: United States Environmental Protection Agency
Duration:36 months (1987-1990)
Amount: $240,000
Project Role: Co-PI
Agency: California Air Resources Board
Duration:18 months (7/90-12/91)
Amount:$84,000
Project Role: Co-PI
Agency: University of California, Riverside
Duration: 12 months (07/87-07/88)
Amount: $70,000
Position: Co-PI
Agency: California Air Resources Board; Contract No. A5-155-33
Duration: 18 months (1986-1987)
Amount: $150,000
Position: Investigator
Agency: California Air Resources Board; Contract No. A4-133-33
Duration: 24 months (1985-1987)
Amount: $250,000
Position: Investigator
Agency: Toxic Substance Research and Teaching Program, University of California, Davis
Duration: 12 months (1986-1987)
Amount: $50,000
Position: Co-PI
Agency: California Air Resources Board; Contract No. A3-132-33
Duration: 18 months (1984-1986)
Amount: $140,000
Position: Investigator
Agency: United States Department of Energy
Duration: 72 months (1981-1987)
Position: Co-PI
Agency: United States Department of Energy
Duration: 72 months (1980-1986)
Position: Investigator
Agency: United States Environmental Protection Agency
Duration: 60 months (1980-1985)
Amount:$500,000
Position: Investigator
PROFESSIONAL EXPERIENCE AND SERVICE
1997-Present President, Toxicologist and Pathologist
Toxi-Health International
150 Bloom Dr., Dixon, CA 95620
March, 2000- Department of Molecular Biology
August, 2001 Research project to test the antifibrotic effects
of Pirfenidone in rat-V-Kidney Fibrosis model
1996-June, 1997 Toxicology Information Specialist and Outreach Coordinator, Center for Environmental Health Sciences.
University of California Davis, Davis, CA 95616
1991-1996 Assistant Research Toxicologist.
Institute of Toxicology & Environmental Health
University of California Davis, Davis, CA 95616
1991-1996 Member of Review Board
Bulletin of Environmental Contamination and
Toxicology.
1991-1992 Served as faculty advisor for 72 undergraduate students of various academic disciplines. (5-10 hours per week)
University of California Davis, Davis, CA 95616
1986-1990 Staff Research Associate IV, Toxicologist
Institute of Toxicology & Environmental Health
University of California Davis, Davis, CA 95616
1979-1986 Staff Research Associate II, Toxicologist
Institute of Toxicology and Environmental Health
University of California Davis, Davis, CA 95616
MEMBERSHIPS & ASSOCIATIONS
PATENT
U.S. Patent Number: 5,686,217
Patent Date: November 11, 1997
use of biomarkers in saliva to evaluate the toxicity of agents and the functions of tissues in both biomedical and environmental allplications.
PUBLICATIONS
I. Articles:
1982 Wei, C. I., M. A. Al-Bayati, M. R. Culbertson, L. S. Rosenblatt, and L. D.
Hansen. Acute toxicity of ammonium metavanadate in mice. Journal of Toxicology and Environmental Health 10: 673-687.
1984 Raabe, O. G., M. A. Al-Bayati, F. Gielow, J. P. Schreider, and N. J.Parks. Studies
of the distribution in beagles of Pu-241 after intratracheal instillation of ultrafine insoluble particles. Health Physics 47:210.
1987 Knaak, J. B., J. Schreider, O. G. Raabe, M. A.Al-Bayati and B. W. Wilson. The
percutaneous absorption of oxidazan in the adult female rat. In: Pesticide Science and Biotechnology. Greenhalgn, R. and Roberts, T. R. (eds.), Blackwell Scientific Publications, pp. 545-548.
1987 Knaak, J. B., M. A. Al-Bayati, F. Gielow, and O. G. Raabe. Safety related to
exposure: Dermal dose-red cell cholinesterase response curves for Ethoprop and Mocap 6 EC. Bulletin of Environmental Contamination Toxicology 38: 834-839, Springer-Verlag New York Inc.
l988 Raabe, O. G., M. A. Al-Bayati, S. Teague, and A. Rasolt. Regional deposition of
inhaled monodisperse coarse and fine particles in small laboratory animals. Annals of Occupational Hygiene 32(1): 53-63.
1989 Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, J. L. Wiedmann, J. W. Pensyl, J. H. Ross, A. P. Leber, and P. Jones. Mixer-loader-applicator exposure and percutaneous absorption studies involving EPTC herbicide. Chapter 22. In: Biological Monitoring for Pesticide Exposure: Measurement, Estimation,and Risk Reduction, Wang, R. G. M., C. A. Franklin, R. C. Honeycut, and J. C. Reinert (eds.), American Chemical Society, Washington, DC., pp. 288-303.
1989 Al-Bayati, M. A., S. N. Giri, O. G. Raabe, L. S. Rosenblatt, and M. Shifrine. Time and dose-response study of the effects of vanadate on rats: Morphological and Biochemical changes in organs. Journal of Environmental Pathology, Toxicology and Oncology 9(5): 435-455.
1990 Al-Bayati, M. A., S. N. Giri and O. G. Raabe. Time and dose-response study of the effects of vanadate on rats: Changes in blood cells and serum elements. Journal of Environmental Pathology, Toxicology, and Oncology 10(4-5): 206-213.
1990 Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, and J. N. Blancato. In vivo percutaneous absorption studies in rat: Pharmacokinetics and modeling of isofenphos absorption. In: Prediction of Percutaneous Penetration: Methods, Measurements, and Modelling. Scott, R. C. (ed), IBC Technical, England.
1991 Al-Bayati, M. A., O. G. Raabe, S. N. Giri, and J. B. Knaak. Distribution of vanadate in rat following subcutaneous and oral exposure. Journal of the American College of Toxicology 10(2): 233-241.
1992 Al-Bayati, M. A., M. R. Culbertson, J. P. Schreider, L. S. Rosenblatt, and O. G. Raabe. The lymphotoxic action of vanadate. Journal of Environmental Pathology, Toxicology, and Oncology, Volume II, No.2.
1992 Knaak, J. B., M. A. Al-Bayati and O. G. Raabe. Physiologically-based pharmacokinetics modeling to predict tissue dose and cholinesterase inhibition in workers exposed to organophosphorus and carbamate pesticides. In: Health Risk Assessment Through Dermal and Inhalation Exposure and Absorption of Toxicant, G.M. Wang, J.B. Knaak, and HI Maibach (eds.). CRC Press, Boca Raton, FL.
1992 Mohammed A. Al-Bayati, Otto G. Raabe, and Stephen V. Teague. Effect of inhaled dimethylselenide in the Fischer 344 male rat. Journal of Toxicology and Environmental Health 37:549-557.
1993 Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, J.N. Blancato. Development of
in vitro Vmax and Km Values for the metabolism of isofenphos by P-450 liver enzymes in animals and human. Toxicology and Applied Pharmacology 120:106-113.
1993 Sidney M. Gospe, Jr. and Al-Bayati, M. A. Comparison of oral and inhalation exposures to toluene. American College of Toxicology, 13(1): 21-32.
1994 Raabe, O. G., D. W. Wilson, M. A. Al-Bayati, W. J. Hornof and L. S. Rosenblatt. Biological effects of inhaled pollutant aerosols. Ann. Occup. Hyg. Vol. 38 Supplement 1. pp. 323-330.
1994 Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, and J. N. Blancato. Prediction of anticholinesterase activity and urinary metabolites of isofenphos: Use of apercutaneous physiologically based pharmacokinetic-physiologically based pharmacodynamic model. In: Biomarkers of Human Exposure to Pesticides, Chapter 17, Saleh, MA, Blancato, JN, and Nauman, CH (eds.). American Chemical Society Symposium Series 542, Washington, D.C.
1995 Knaak, J. B., M. A. Al-Bayati, and O. G. Raabe. Development of partition coefficients, Vmax and Km values, and allometric relationships. Toxicology letters 79, 87-98.
1995 Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, and J. N. Blancato. Use of a multiple pathway and multiroute PBPK model for predicting OP toxicity: In American Chemical Society Symposium: Field Application of Biomarkers for Agrochemicals. April 3-7, Anaheim, CA.
1996 Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, and J. N. Blancato. Use of a multiple pathway and multiroute PBPK model for predicting OP toxicity: Field Application of Biomarkers for Agrochemicals. In American Chemical Society Symposium Series 643, Washington, D.C., pp.206-228
1996 Raabe, O.G. and Al-Bayati, M.A. Distribution and retention of inhaled vanadium on inert airborne particles. Ann. Occup. Hyg., Vol.41, supplement 1.
Medical Journal. January 30, 2002 ( http://bmj.com/cgi/eletters/324/7331/237 ).
2002 [ http://bmj.com/cgi/eletters/324/7335/446/a#20389 ].
[ http://bmj.com/cgi/eletters/324/7337/564#20541
].
2002 Mohammed Ali Al-Bayati, Yan Xie, F. Charles Mohr, solomon B. Margolin, Shri
N. Giri. Effect of Pirfenidone Aganist Vanadate-Induced Kidney Fibrosis in Rats.
Biochemical Pharmacology ( In Press).
III. Reports:
1987 Raabe and Al-Bayati, M.A. Gastrointetinal-tract Uptake of Benzene in drinking water in rats. Submitted to the University of California Toxic Substance and Teaching Program, Davis, CA.
1988 Raabe, O.G. Knaak, J.B. , Al-Bayati, M.A., Uyeminami, D., and Gielow, F. Development of Multiple Route Compound Pharmacokinetic Models: Development of a physiological Pharmacokinetic Model for an Organophosphate: isofenphos. Submitted to Exposure Assessment group, USEPA, Wahington, DC. September 20, 1988.
1988 Raabe, O.G., Al-Bayati, M.A., Gielow, F., Teague, S., and Uyeminami. Inhalation Uptake of Xenobiotic Vapors by People. Submitted to the Biological effects Research Section, California Air Resources Board, SACRAMENTO, California (CARB Contract NO. A5-155-33). March 1988.
1992 Raabe, O.G., Al-Bayati, M.A., Shulec, P.D., Gielow, F., Uyeminami, and N. Shimasaki. Dermal Absorption of Methanol and methanol/Gasoline Mixtures. Submitted to the Biological effects Research Section, california Air Resources Board, Sacramento, California (CARB Contract NO. A933-186). December 1992.
PRESENTATIONS AND ABSTRACTS
histochemical studies in adrenal gland of buffalo in case of cystic and inactive ovaries.
X World Congress of Buiatrics, Aug. 16-19. Mexico.
1984 Raabe, O. G., M. A. Al-Bayati, F. Gielow, J. P. Schreider, and N. J.Parks. Studies of the distribution in beagles after intratracheal instillation as ultrafine insoluble particles. Presented at the Health Physics Society Annual Meeting, June. New Orleans, LA.
1985 Raabe, O. G., M. A. Al-Bayati, and F. Gielow. Metabolism of Pu-241 in beagles and non-human primates after intratracheal instillation of ultrafine insoluble particles. Presented at the Health Physics Society Annual Meeting, May. Chicago, IL,.
1988 Al-Bayati, M. A., S. N. Giri, O. G. Raabe, M. Shifrine, and L. S.Rosenblatt. Chronic renal toxicity of vanadium in rat. FASEB Meeting , May 1. Las Vegas, Nevada, USA,.
1988 Knaak, J. B., M. A. Al-Bayati, and O. G. Raabe. Study on the pharmacokinetics and toxicity of isofenphos in rat. FASEB Meeting, May 1. Las Vegas, Nevada, USA,.
1990 Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, and J. N. Blancato. In vitro metabolism of isofenphos by human and animal liver. American Chemical Society Meeting, April 22-27. Boston, MA.
1992 Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, and J. N. Blancato. Prediction of anticholinesterase activity and urinary metabolites of isofenphos: Use of a percutaneous physiologically based pharmacokinetic- physiologically based pharmacodynamic model. American Chemical Society Meeting, August 23-28. Washington, D.C.
1993 Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, and J. N. Blancato. Development of
in vitro Vmax and Km values for the metabolism of isofenphos by P-450 liver enzymes in animals and human. Society of Toxicology 32nd Annual Meeting, March 14-18, New Orleans, Louisiana.
1994 M. A. Al-Bayati, J.B. Knaak, O. G. Raabe, and J. N. Blancato. The effects of enzyme inducers and inhibitors on the metabolism of isofenphos by rat liver P450 enzymes. Society of Toxicology 33th Annual Meeting, March 13-18, Dallas, Texas.
Pharmacokinetics of Isofenphos in Male Guinea Pig. Society of Toxicology 34th Annual Meeting, March 5-9. Baltimore, Maryland.
2001 Al-Bayati MA,Xie Y,Mohr CF,Margolin SB,Giri SN. Amelioration of Vanadium
Society of Toxicology 40 thInduced Kidney Fibrosis by Pirfenidone in Rats.
AnnualMeeting, March 25-30. San Francisco, California.